CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

NCT06822881 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)
Systemic Sclerosis (SSc)

Interventions

DRUG: CAR-T Therapy

Sponsor

Beijing GoBroad Hospital

Collaborators

[object Object]